Lecture 9 and 10: Calcium Metabolism I and II Flashcards Preview

Reproduction, Development and Aging COPY > Lecture 9 and 10: Calcium Metabolism I and II > Flashcards

Flashcards in Lecture 9 and 10: Calcium Metabolism I and II Deck (50)
Loading flashcards...
1
Q

ECF ca2+ levels are _____

A

Tightly controlled, which suggests that it’s an important physiolgoical phenomenon

2
Q

What form of Ca2+ regulates PTH?

A

Ionised/free form

In the ECF, ECF, about 50% of calcium is in the free/ionised/bioactive form

3
Q

What organs are closely related to Ca2+ and phosphate?

A

Bone acts as a major reservoir for calcium and phosphate

The kidney regulates the excretion of calcium. It is an important contributor for regulation of rapid response and serum calcium

4
Q

How does the PTH stimulate release of Ca2+?

A
  1. Stimulates osteoclastic bone resorption
  2. Stimulates renal tubular reabsorption of Ca++
  3. Stimulates _renal 1-hydroxylation of 25(OH)D (_long loop effect)- form bioactive form of vitamin D. This stimulate intestine Ca2 and K absorption

So directly or indirectly Restores serum Ca++ by acting on all effector organs

5
Q

_____ is the main regulator of serum calcium

A

Parathyroid hormone is the main defender of serum calcium

So directly or indirectly Restores serum Ca++ by acting on all effector organs

6
Q

Describe the effect of plasma Ca2+ on PTH

A

1) Decrease in plasma Ca2+
2) Calcium sensing receptor in the Parathyroids (chief cells) increase production of Parathyroid
3a) Increases Bone reabsorption of Ca2+ and Phosphate
3b) Increases renal tubular reabsorption of Ca2+. This decreases reabsorption of phosphate
3c) Stimulates renal 1-hydroxylation of 25(OH)D (long loop effect)- form bioactive form of vitamin D. This s_timulate intestine Ca2 and K absorption_

7
Q

What are parathyroid hormones?

A

Hormone secreted by the parathyroid glands that is important in bone remodeling, which is an ongoing process in which bone tissue is alternately resorbed and rebuilt over time.

PTH is secreted in response to low blood serum calcium(Ca2+) levels.

8
Q

What is Parathyroid hormone release regulated by? (3)

A

1) Release is most importantly regulated by Serum ionized calcium level. (negative regulator)
2) Also regulated in some extent by serum phosphate, so that high levels of serum phosphate as a pharmacologic agent can stimulate PTH production (not major)
3) Also 1,25 dihydroxyvitamin D (negative regulator)

9
Q

Describe the composition of ECF calcium

A

45-50% ionized, bioactive

5-10% complexed with anions eg HCO3

45-50% protein-bound, albumin and globulins

10
Q

What happens if the Ca2+ levels are high

A

Schematic to reinforce the idea that there are specific cell membrane-bound receptor for ionised-calcium at the membrane of PTH chief cells.

In such a way that if the level of cA2+ is high, the receptor conformation changes and signals to the cells to switch off parathyroid hormone production and secretion.

Subsequent reduction in PTH

If the receptor function is disordered, (constantly switched off or switch off), will result in perdubation of Ca2+/PTH axis.

11
Q

Describe the DIRECT renal-handling of Ca2+

A

Another place (independent of PTH). CaR is expressed is the renal tubule

Basolateral membrane of renal tubular cells

ECF Ca2+ levels can module the reabsorption of Ca2+ from the urine back into the body

The receptor will signal to reduce further reabsorption of CA2+ into the ECF

12
Q

Describe Vit D and Ca2+

A

Vit D is technically a hormone (we produce it due to UVB exposure)

Through a series of steps, you produce calidiol (25OD H) then hydroxylation to 1,25(OH2)D (1,25 vitamin D)

Vitamin D then i_ncreases absorption of Ca2+ and Pi (fractionally)_

13
Q

Is Calcitonin is a physiological regulator of serum calcium?

A

NO

14
Q

Is the Parathyroid hormone-related peptide a regulator of serum calcium?

A

No, it is NOT a physiological regulator of serum calcium

It is an important paracrine regulator of breast, skin and bone development

15
Q

What is PTHrP?

A

Parathyroid hormone-related peptide (PTHrP)

  • Important paracrine regulator of breast, skin and bone development
  • NOT a physiological regulator of serum calcium
    • PTH is usually suppressed due to elevated serum calcium concentrations.
    • A variety of other mechanisms lead to inappropriate hypercalcemia in hypercalcemia of malignancy. These include:
      • -Impaired renal function due to a tumor or its treatment
      • -Osteolytic activity within bony metastases
      • -Release of calcemic cytokines by non-osteolytic bony metastases
      • -Secretion of humoral factors mimicking PTH action (humoral hypercalcemia of malignancy: HHM), usually associated with secretion of parathyroid hormone-related peptide (PTHrP) by the primary tumor (or more commonly its metastases)
      • -Other as yet unknown factors
  • Produced in excess by some cancers, esp epithelial cell tumours → humoral hypercalcemia of malignancy (HHM)
    • Most c_ommon cause of cancer-associated hypercalcemia_
    • Acts v similarly to PTH, signals via PTHR1
    • Hypercalcemia can be severe and life-threatening
16
Q

What is produced in excess by some cancers, esp epithelial cell tumours?

A

Parathyroid hormone-related peptide (PTHrP)

17
Q

What are the causes of hypercalcemia?

A

PTH-dependent, ↑sCa++, ↑/N PTH (due to excess of PTH)

  • Primary hyperparathyroidism
  • Bengin Familial Hypercalcemia: FHH/inactivating CaSR mutations (tricked into thinking Ca2+ concentration is lower than it is)
    • High Ca2+, High PTH, Low Ca2+ excreted in urine

PTH-independent, ↑sCa++, ↓ PTH

  • a_. Cancer_
      • almost always releated to increased PTHrP (parathyroid hormone-related peptide)
      • increased bone reabsorption: extensive lytic bone disease (myeloma)
      • 1,25 dihydroxyvitamin D dependent hypercalcemia (v rare)
  • b. Vitamin D-dependent
      • Sarcoidosis
      • Vitamin D intoxication
18
Q

If someone comes in with hypercalcemia, what should you do?

A

Do a PTH test to determine whether the cause is PTH-dependent or PTH-independent

Raised PTH= PTH-dependent diseases

Decreased PTH = PTH-independent diseases

19
Q

How does PThRP cause hypercalcemia?

A

NOT a physiological regulator of serum calcium

Hypercalcemia of malignancy is typically not due to excess parathyroid hormone (PTH). In these disorders, PTH is usually suppressed due to elevated serum calcium concentrations. A variety of other mechanisms lead to inappropriate hypercalcemia in hypercalcemia of malignancy. These include:

  • Impaired renal function due to a tumor or its treatment
  • Osteolytic activity within bony metastases
  • Release of calcemic cytokines by non-osteolytic bony metastases
  • Ectopic 1-alpha hydroxylase activity in tumor tissues
  • Secretion of humoral factors mimicking PTH action (humoral hypercalcemia of malignancy: HHM), usually associated with secretion of parathyroid hormone-related peptide (PTHrP) by the primary tumor (or more commonly its metastases)
  • Other as yet unknown factors
20
Q

What are the causes of hypocalcemia?

A

1) Hypoparathyroidsim

  • due to postsurgical, post neck irradiation
  • autoimmune disease
  • genetic, including activating CaSR mutations (even though serum calcium levels are low, it mimics )
  • severe hypomagnesaemia

2) Parathyroid hormone resistance

-High parathyroid, but the receptors are resistant.

3) Abnormaltieis of vitamin D metabolism

  • Vitamin D deficiency (deficient 1a-hydroxylation)
  • Renal failure (vit D resistance)
21
Q

Describe 3 things that regulate the level of phosphate in our body

A
  • lots of overlap with Ca2+ metabolism
    1) Vitamin D plays an important role in absorption of Potassium from diet
    2) PTH modulates fluctuation of P from within bone to ECF. Also at a kidney level, stimualtes the excretion of P

**3) Phosphatonins (group of proteins) which importantly regulate the renal excretion- to stimulate phosphoturia (serum phosphate levels fall)

22
Q

What organs are related to phophate metabolism

A

1) Intestine (absorbed)
2) Kidney (excretion)
3) Bone (depositied in bone)

23
Q

Describe the important contributers to determine the level of phosphate in our plasma

A

1) Diet (some level)
2) Fluxes between intracellular and extracellular fluid (more important)
3) Kidney (source of tissue responsible for hyperphosphatemia)

24
Q

What are the causes of hyperphosphatemia?

A

1) Increased input
- IV phosphate,
- cell death
2) Decreased excretion-
- renal failure**
- PTH deficiency
- PTH resistance

25
Q

What are some causes of hypophosphatemia?

A

1) Inadequate GI absorption (e.g. vitamin D deficiency)
2) most common: Intracellular shift
- respiratory alkalosis, usually self-limiting
- prolongued intense exercise
- refeeding of malnourished patients
3) Renal loss
- ↑PTH
- ↑phosphatonins
- alcoholism

26
Q

Where are the phosphatonins from and what does it cause?

A

1) FGF23 is Derived from bone
2) Inhibitor of 1a-hydroxylase enzme, which leads to the reduction of production of 1,25(OH2)D
2) Decrease NaPi
3) Both decrease phosphate reabsorption
4) Hypophosphatemia

27
Q

What is the NPT2 transporter at the renal regualted by?

A

1) PTH
2) *** FGF-23 (phosphatonins)

28
Q

What is ONE major player in phosphate-losing conditions

Explain how it works

A

1) FGF-23 (phospahtonin) normally comes out of bone (made from oestoclasts), inhibts 1a-OHase which leads to reduction in vitD production and therefore intestinal _Ca and Pi absorptio_n = Phosphate Loss
2) FGF-23 also inhibits phosphate transporters, which increases renal phosphate exrection, which leads to hypophosphatemia.

29
Q

What is FGF23 regulated by?

A

Phex- regulated by osteoblast.

Phex inactivates FGF23

30
Q

What is FGF23 and what is it produced by?

A

Type of Phosphatonin

Produced by osteocytes

31
Q

How might high levels of FGF23 be achieved?

What does this result in?

A

1) Tumours (derived from mesenchymal cell origin)
2) Abnormal PHEX

32
Q

Diagnose

  • 60 year old man with 2 year history of tiredness
  • One previous episode of haematuria
  • Investigations
    • I_ncreased plasma calcium_
    • Normal Plasma albumin
    • Increased ionized calcium
    • Lowish-but normal- Plasma phosphate
    • Decreased TmP/GFR
    • Increased 24 hour urine calcium
    • Normal ALP
    • Increased PTH level
A

Hypercalcemia

Low GFR= low ability to reabsorb calcium

Primary hyperparathyoidism (many have no symptoms and are common in older patients) (Increased PTH levels)

Treatment:

-Neck expoloration, and the inferior parathyroid adenoma was removed.

33
Q

What are the 4 main causes of hypercalcaemia?

A

1) Primary hyperparathyoidism
2) Cancer-associated
3) Vitamin D toxicity (endogenous, exogenous)
4) Familial Benign Hypercalcaemia (FHH/FBH)

95% fall into one of these categories

34
Q

Diagnose

  • 68 year old man
  • L sided chest pain
  • Cigarette smoker
  • History
    • Gout
    • Hypertension
    • Chronic bronchitis
  • Xray
    • Pleural mass- squamous cell cancer
  • 12 months later
    • Pyloric ulceration
    • Weight loss
    • Polyuria
    • Increased calcium levels
    • Decreased albumin
    • Decreased Phosphate levels
    • Decreased creatinine
    • Low PTH
A

-Hypercalcemia

-low PTH levels suggest this is PTH-independent Hypercalcemia

caused by

-Cancer (solid tumours secreting PTHrP)

(or multiple skeletal metastases or bone marrow malignancy)

Parathyroid Hormone-related pepitide

35
Q

What dos PTHrP do?

A

-bone

1) Stimulate calcium release in bone

-kidney

2) Raise plasma calcium

3) Lower plasma phosphate

36
Q

Diagnose

  • A 74 year old woman presents with a 3/12 history of bone pain and decreasing mobility
  • She gives two year history of diarrhoea and weight loss
  • Diagnosed with anaemia secondary to folate and iron deficiency
  • Physical examination
    • V. thin
    • Muscle wasting
    • Bone pain*
  • Biochemistry
    • Low plasma calcium
    • Low plasma phosphate
    • High ALP
    • Low GGT
    • Low Creatinine
    • Increased PTH
    • Serum 25 OH vit D is undectable
    • Increased Faecal fat assessment
A

Hypocalcemia

This combination of biochemistry suggests- osteomalacia (softening of bone)

Malabsorbing (faecal fat assessment)

Diagnonsis: Coeliac disease

37
Q

What is osteomalacia?

A

Failure of bone to mineralise: Softening of the bones, typically through a deficiency of vitamin D or calcium.

Characterised by lots of unmineralized osteoid (bone): It is a histological diagnosis

Osteomalacia in childhood causes rickets

38
Q

What are the causes of vit D deficiency?

A

1) Inadequate exposure to sunlight (most common)
2) Enzyme induction
3) Impaired 1ahydorxlase (due to renal disfunction)
4) Poor diet/GI disease

39
Q

Diagnose

  • 30 year old man, presented with grand mal seizures
  • Decreased serum Ca2+
  • Slightly increased PO4
  • Increased PTH
  • Normal serum creatinine
  • Normal 25(OH) vit D
  • Physical
    • Short stature
    • Short 4th metacarpal and metatarsal
    • fT4 11pmlol/L, TSH 7mlIU/ml
A

Hypocalcaemia

PTH-dependent

Diagnosis: Pseudohypoparathyroidsim (PTH resistance)

40
Q

What is this indicative of?

Short 4th and 5th metacarpals

A

Pseudohypoparathyroidsim (PTH resistance)

41
Q

What is a common feature in Pseudohypoparathyroidsim (PTH resistance)?

A

Short 4th and 5th metacarpals

42
Q

What often causes Pseudohypoparathyroidsim (PTH resistance)?

A

Mutations in Gs-a

43
Q

Diagnose

  • Flu-like ilness + anorexia
  • Vomiting and nusea
  • Abdo pain-central costant
  • Severe muscle cramps
  • PMHx is unremarkable
  • Afrebrile
  • Carpopedal spasm (often wiwth hypocalcemia)
  • Hyperactive tendon reflexes
  • Upper resp tract infection
  • Investigations
    • Decreased calcium
    • Decreased phosphate
    • Undetectable PTH
    • Normal Albumin
    • No history of surgery
    • Normal magnesium level
A

Hypocalcaemia

(Hypoparathyroidism ?)

(no surgery, no hypomagnesaemia, no iron overload)

= Idiopathic/Genetic (had family history)- autosomal dominant hypercalciuric hypocalcaemia.

44
Q

What are the 2 types of Calcium Receptor mutations (found in bones and renal tubules)

A

Activating (green) mutations (Autosomal Dominant hypocalcemia)

Inactivating (red) mutations (Benign familial hypocalcemia)

  • receptor is inactivated/less activated
  • lower level of calcium is present, but increased PTH is released
  • Low urinary Ca2+ secretion occurs

Optimal management for both: do nothing if asymptoatic

If recurrent symptoms: Small doses of vit D

45
Q

What is the management plan for Autosomal dominant hypocalcemia?

A

Optimal management for both:

Do nothing if asymptoatic (if they’re treated with vit D, they can get hypercalciuria with nephrocalcinosis)

If recurrent symptoms: Small doses of vit D

46
Q

Describe ADHH features

A

autosomal dominant hypocalcaemia with hypercalciuria

1) Autosomal dominant inheritance
2) Hypocalcemia- usually asymptomatic
3) Mild hypomagnesaemia (sometimes)
4) Detectable/’high’ levels of PTH
5) Higher uirnary calcium excretion

47
Q

When would you suspect that someone may have FHH?

A

Familial hypocalciuric hypercalcemia

PTH is in the ‘normal range’ despite high Ca2+

Family history of hypercalcemia

48
Q

How do you diagnose FHH?

A

Familial hypocalciuric hypercalcemia

Screening immediate relatives (Autosomal Dominant inheritance)

Ratio of fasting urine calcium to creatinine clearance (Cit D replete, no thaizides)

CaR genotyping (currently in research)

49
Q

Diagnose

  • 79 year old English tourist
  • In ED 3 days after a minor fall
  • Twisted her R leg, with increasing R hip pain and difficulty mobilising
    • Trochinteric fracture
  • 4kg weight loss in last year
  • Blood Tests
    • Low serum phosphate
    • Increased ALP
    • Other liver ezymes were normal (suggest has osteomalacia)
    • PTH was high
    • Normal 25OHD
    • substatial increase in Serum FGF23
A

Hypophosphatemia

Tumour - cause increase FGF23

50
Q

If someone has increased ALP but other liver enzymes are normal, what is this indicative of?

A

osteomalacia